• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structure-activity relationship studies on the novel neuropeptide orphanin FQ.

作者信息

Reinscheid R K, Ardati A, Monsma F J, Civelli O

机构信息

CNS Research, Pharma Division, F. Hoffmann-La Roche AG, CH-4070 Basel, Switzerland.

出版信息

J Biol Chem. 1996 Jun 14;271(24):14163-8. doi: 10.1074/jbc.271.24.14163.

DOI:10.1074/jbc.271.24.14163
PMID:8662940
Abstract

The heptadecapeptide orphanin FQ (OFQ) is an endogenous ligand to an opioid-like G protein-coupled receptor. Although the primary structure of OFQ exhibits some similarity to the opioid peptides, OFQ is not recognized by opioid receptors nor does the OFQ receptor bind opioid ligands. In order to investigate the structural determinants of this ligand/receptor selectivity, we conducted a systematic structure-activity study on OFQ to characterize which sites of the molecule are important for receptor activation. Alanine- and D-amino acid-scanning mutagenesis revealed several residues in the amino-terminal half of OFQ which participate in both receptor binding and activation. Most strikingly, the Phe1 position could be changed to a tyrosine without loss of biological activity. In addition, the OFQ receptor seemed to require recognition of the complete peptide molecule for activation. These results indicate that the mode of interaction of OFQ with its receptor may be different from that of the opioid peptides with their respective receptors and might therefore account for the observed selectivity.

摘要

相似文献

1
Structure-activity relationship studies on the novel neuropeptide orphanin FQ.
J Biol Chem. 1996 Jun 14;271(24):14163-8. doi: 10.1074/jbc.271.24.14163.
2
Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.孤啡肽:一种激活阿片样G蛋白偶联受体的神经肽。
Science. 1995 Nov 3;270(5237):792-4. doi: 10.1126/science.270.5237.792.
3
Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides.[3H]孤啡肽FQ与125I-酪氨酸14-孤啡肽FQ与孤啡肽FQ受体的相互作用:动力学以及阳离子和鸟嘌呤核苷酸的调节作用
Mol Pharmacol. 1997 May;51(5):816-24. doi: 10.1124/mol.51.5.816.
4
Primary structure and tissue distribution of the orphanin FQ precursor.孤啡肽原的一级结构与组织分布
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8677-82. doi: 10.1073/pnas.93.16.8677.
5
Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.环阿片肽/孤啡肽FQ类似物c[Cys10,14]N/OFQ(1 - 14)NH2和c[Nphe1,Cys10,14]N/OFQ(1 - 14)NH2的药理学特征
Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):528-37. doi: 10.1007/s00210-003-0821-5. Epub 2003 Nov 4.
6
Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities.描绘孤啡肽FQ和强啡肽A药理学选择性的结构。
J Biol Chem. 1998 Jan 16;273(3):1490-5. doi: 10.1074/jbc.273.3.1490.
7
Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor.痛稳素:一种由痛敏肽/孤啡肽FQ前体基因编码的新型神经肽。
Peptides. 2000 Jul;21(7):1101-9. doi: 10.1016/s0196-9781(00)00247-3.
8
Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain.
Biochem Biophys Res Commun. 1997 Jan 13;230(2):462-5. doi: 10.1006/bbrc.1996.5867.
9
Cyclic AMP analogs induce synthesis, processing, and secretion of prepro nociceptin/orphanin FQ-derived peptides by NS20Y neuroblastoma cells.环磷酸腺苷类似物可诱导NS20Y神经母细胞瘤细胞合成、加工和分泌前痛敏肽/孤啡肽FQ衍生肽。
DNA Cell Biol. 1999 Jan;18(1):51-8. doi: 10.1089/104454999315619.
10
Nociceptin/orphanin FQ increases ANP secretion in neonatal cardiac myocytes.
Life Sci. 2002 Jan 18;70(9):1065-74. doi: 10.1016/s0024-3205(01)01474-6.

引用本文的文献

1
The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder.内源性阿片肽的前世今生:对其合成、时空动态的最新认识及其在酒精使用障碍中的临床影响。
Neuropharmacology. 2023 Mar 1;225:109376. doi: 10.1016/j.neuropharm.2022.109376. Epub 2022 Dec 11.
2
A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis-Clinical Implications.结肠炎中大麻素受体与孤啡肽受体之间的相互作用——临床意义
J Clin Med. 2022 Nov 10;11(22):6675. doi: 10.3390/jcm11226675.
3
Copper-Mediated Radiocyanation of Unprotected Amino Acids and Peptides.
铜介导的未保护氨基酸和肽的放射性氰化反应。
J Am Chem Soc. 2022 Apr 27;144(16):7422-7429. doi: 10.1021/jacs.2c01959. Epub 2022 Apr 18.
4
Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.聚焦于孤啡肽/阿片肽受体在疼痛治疗中的作用。
Molecules. 2022 Jan 18;27(3):595. doi: 10.3390/molecules27030595.
5
GRKs as Key Modulators of Opioid Receptor Function.G 蛋白偶联受体激酶作为阿片受体功能的关键调节因子。
Cells. 2020 Nov 2;9(11):2400. doi: 10.3390/cells9112400.
6
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH.阿片胜肽/孤啡肽受体的偏性激动作用:N/OFQ(1-13)-NH 的结构活性研究。
J Med Chem. 2020 Oct 8;63(19):10782-10795. doi: 10.1021/acs.jmedchem.9b02057. Epub 2020 Sep 24.
7
Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System.孤啡肽/强啡肽系统对腹侧被盖区回路的差异调节。
eNeuro. 2020 Oct 19;7(5). doi: 10.1523/ENEURO.0376-19.2020. Print 2020 Jul/Aug.
8
Managing Parkinson's disease: moving ON with NOP.管理帕金森病:与 NOP 一起前行。
Br J Pharmacol. 2020 Jan;177(1):28-47. doi: 10.1111/bph.14893. Epub 2020 Jan 3.
9
On the inhibition of capsaicin response in dorsal root ganglion neurons by nobilamide B and analogues: a structure-activity relationship study.诺比酰胺B及其类似物对背根神经节神经元辣椒素反应的抑制作用:构效关系研究
Medchemcomm. 2018 Aug 15;9(10):1673-1678. doi: 10.1039/c8md00304a. eCollection 2018 Oct 1.
10
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands.孤啡肽/强啡肽原受体二聚配体的结构和构象活性研究。
Sci Rep. 2017 Apr 6;7:45817. doi: 10.1038/srep45817.